FrancophonIA/ELRC3.0 huggingface dataset:
English: These include: - change in the injection area, - improved insulin sensitivity (e.g., by removal of stress factors), - unaccustomed, increased or prolonged physical activity, - intercurrent illness (e.g. vomiting, diarrhoea), - inadequate food intake, - missed meals, - alcohol consumption, - certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), - concomitant treatment with certain other medicinal products.
Croatian: Oni obuhvaćaju: - promjenu područja injiciranja, - poboljšanu osjetljivost na inzulin (npr. uklanjanjem čimbenika stresa), - povećanu ili dugotrajnu tjelesnu aktivnost na koju bolesnik nije navikao, - interkurentnu bolest (npr. povraćanje, proljev),
English: Pens in use must not be stored in the refrigerator.
Croatian: Brizgalice u uporabi ne smiju se odlagati u hladnjak.
English: Such reactions to insulin (including insulin glargine) or the excipients may, for example, be associated with generalised skin reactions, angiooedema, bronchospasm, hypotension and shock, and may be life-threatening.
Croatian: Takve reakcije na inzulin (uključujući inzulin glargin) ili na pomoćne tvari mogu, primjerice, biti povezane s generaliziranim kožnim reakcijama,
English: The pen should be used as recommended in the information provided with the device.
Croatian: Brizgalicu je potrebno koristiti sukladno preporukama navedenima u informacijama priloženima uz taj medicinski proizvod.
English: Step 13:
Croatian: 13. korak:
English: • Do not store the pen with the needle attached to prevent leaking, blocking the needle, and air from entering the pen.
Croatian: • Da biste spriječili istjecanje inzulina, začepljenje igle i ulazak zraka u brizgalicu, ne smijete čuvati brizgalicu s pričvršćenom iglom.
English: Selecting your dose
Croatian: Vašom dozom.
English: Step 11:
Croatian: 11. korak:
English: How to store ABASAGLAR
Croatian: Kako primjenjivati lijek ABASAGLAR
English: Musculoskeletal and connective tissue disorders
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva mialgija
English: Close metabolic monitoring is recommended during the switch and in the initial weeks thereafter.
Croatian: Tijekom prijelaza i u prvim tjednima nakon toga preporučuje se pomno nadzirati metabolizam.
English: Empty pens must not be re-filled and must be properly discarded.
Croatian: Prazne brizgalice ne smiju se ponovno puniti i moraju se propisno zbrinuti.
English: Injection sites must be rotated within a given injection area from one injection to the next.
Croatian: Mjesto injiciranja mora se promijeniti kod svake injekcije unutar preporučenog područja primjene.
English: Switch from twice daily NPH insulin to ABASAGLAR To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with ABASAGLAR should reduce their daily dose of basal insulin by 20-30 % during the first weeks of treatment.
Croatian: Kako bi se umanjio rizik od noćne i ranojutarnje hipoglikemije, bolesnici koji mijenjaju režim liječenja bazalnim inzulinom s liječenja NPH inzulinom dvaput na dan na liječenje lijekom
English: 5sec
Croatian: 5 sek
English: Solution for injection (injection) in pre-filled pen (KwikPen) Clear, colourless solution.
Croatian: Otopina za injekciju (injekcija) u napunjenoj brizgalici (KwikPen).
English: - all other medicines to treat diabetes, - angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure), - disopyramide (used to treat certain heart conditions), - fluoxetine (used to treat depression), - fibrates (used to lower high levels of blood lipids), - monoamine oxidase (MAO) inhibitors (used to treat depression), - pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), - somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone), - sulphonamide antibiotics.
Croatian: - sve druge lijekove za liječenje šećerne bolesti - inhibitore angiotenzin konvertirajućeg enzima (ACE-inhibitore) (koriste se za liječenje nekih srčanih bolesti ili visokog krvnog tlaka) - dizopiramid (koristi se za liječenje nekih srčanih bolesti) - fluoksetin (koristi se za liječenje depresije) - fibrate (koriste se za snižavanje visoke razine masnoća u krvi)
English: Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).
Croatian: Jedan mililitar otopine sadrži 100 jedinica djelatne tvari inzulina glargina (što odgovara 3,64 mg).
English: You can give yourself multiple doses using one pen.
Croatian: Jednom brizgalicom možete primijeniti veći broj doza.
English: Dose Window
Croatian: Prozorčić za odabir doze
English: Factors increasing the susceptibility to hypoglycaemia require particularly close monitoring and may necessitate dose adjustment.
Croatian: Potrebno je osobito pomno nadzirati čimbenike koji povećavaju sklonost hipoglikemiji te prema potrebi prilagoditi dozu.
English: Insulin antibodies
Croatian: Protutijela na inzulin
English: • Pull off the outer needle shield.
Croatian: • Skinite vanjski zatvarač igle.
English: Step 4:
Croatian: 4. korak:
English: Troubleshooting
Croatian: Doziranje
English: The dose indicator should line up with your dose.
Croatian: Pokazivač doze mora biti u ravnini s
English: ABASAGLAR 100 units/mL solution for injection in a cartridge is a clear and colourless solution.
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u ulošku je bistra i bezbojna otopina.
English: Read carefully the "ABASAGLAR KwikPen Instructions for Use" included with this package leaflet.
Croatian: "Upute za uporabu brizgalice ABASAGLAR KwikPen", koje su sastavni dio ove upute o lijeku.
English: • Dose Knob:
Croatian: • Gumb za doziranje:
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - KwikPen.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VANJSKA KUTIJA - KwikPen brizgalica.
English: Hypoglycaemia
Croatian: HIPERGLIKEMIJA
English: Inspect the cartridge before use.
Croatian: Pregledajte uložak prije nego što ga upotrijebite.
English: • Swab
Croatian: • tupfer
English: Step 3:
Croatian: 3. korak:
English: Before travelling consult your doctor.
Croatian: Obratite se svom liječniku za savjet prije putovanja.
English: Step 6:
Croatian: 6. korak:
English: Dose Indicator
Croatian: Naljepnica Pokazivač doze
English: ABASAGLAR is a long-acting insulin.
Croatian: ABASAGLAR je dugodjelujući inzulin.
English: The adverse reaction reports received from post marketing surveillance included relatively more frequent injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) in children and adolescents (≤ 18 years of age) than in adults.
Croatian: U djece i adolescenata mlađih od 18 godina relativno su češće nego u odraslih bolesnika prijavljene pritužbe na reakcije na mjestu injiciranja (bol na mjestu injiciranja, reakcija na mjestu injiciranja) i kožne reakcije (osip, koprivnjača).
English: Paper Tab
Croatian: Papirnati pokrov
English: The pen in use must not be stored in the refrigerator.
Croatian: Brizgalica u uporabi ne smije se odlagati u hladnjak.
English: Instructions for use KwikPen ABASAGLAR 100 units/mL solution for injection in a pre-filled pen Insulin glargine
Croatian: Upute za uporabu KwikPen ABASAGLAR 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin glargin
English: However, only very rarely, this will require a change to your insulin dose.
Croatian: Međutim, promjena doze inzulina bit će potrebna samo u vrlo rijetkim slučajevima.
English: There was less severe hypoglycaemia in the insulin glargine group as well.
Croatian: Isto tako, u skupini koja je primala inzulin glargin bilo je manje slučajeva teške hipoglikemije.
English: ABASAGLAR 100 units/mL injection KwikPen insulin glargine
Croatian: ABASAGLAR 100 jedinica/ml, injekcija KwikPen inzulin glargin s.c. primjena
English: • Put used needles in a closable, puncture-resistant sharps container.
Croatian: • Upotrijebljene igle odložite u neprobojan spremnik za oštre predmete koji se može zatvoriti.
English: The exposure to M1 increases with the administered dose of insulin glargine.
Croatian: Glavni cirkulirajući metabolit u plazmi je M1. Izloženost metabolitu M1 raste s primijenjenom dozom inzulina glargina.
English: Package leaflet: Information for the user ABASAGLAR 100 units/mL solution for injection in a cartridge insulin glargine
Croatian: Uputa o lijeku: Informacije za korisnika ABASAGLAR 100 jedinica/ml otopina za injekciju u ulošku inzulin glargin
English: - diuretics (used to treat high blood pressure or excessive fluid retention), - glucagon (pancreas hormone used to treat severe hypoglycaemia), - isoniazid (used to treat tuberculosis), - oestrogens and progestogens (such as in the contraceptive pill used for birth control), - phenothiazine derivatives (used to treat psychiatric disorders), - somatropin (growth hormone), - sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma), - thyroid hormones (used to treat thyroid gland disorders), - atypical antipsychotic medicines (such as clozapine, olanzapine), - protease inhibitors (used to treat HIV).
Croatian: - simpatomimetičke lijekove (poput epinefrina [adrenalina], salbutamola, terbutalina, koji se koriste za liječenje astme) - hormone štitnjače (koriste se za liječenje poremećaja štitnjače) - atipične antipsihotičke lijekove (kao što su klozapin, olanzapin) - inhibitore proteaze (koriste se za liječenje HIV infekcije)
English: Recap the pen after use to protect from light.
Croatian: Nakon primjene vratiti zatvarač na brizgalicu radi zaštite od svjetlosti.
English: Dose
Croatian: Baciti
English: Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens, progestogens, phenothiazine derivatives, somatropin, sympathomimetic medicinal products (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors.
Croatian: somatropin, simpatomimetičke lijekove (npr. epinefrin [adrenalin], salbutamol, terbutalin), hormone štitnjače, atipične antipsihotike (npr. klozapin i olanzapin) te inhibitore proteaze.
English: Do not rub the area.
Croatian: Ne smije se razrjeđivati.
English: Keep the cartridge in the outer carton in order to protect from light.
Croatian: Uložak čuvati u vanjskom pakiranju radi zaštite od svjetlosti.
English: It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency.
Croatian: bezbojna, vodenasta i ako nema vidljivih krutih čestica.
English: • You can give from 1 to 6080 units in a single injection.
Croatian: • U jednoj injekciji možete injicirati najmanje 1, a najviše 60 80 jedinica.
English: Posology
Croatian: Uložak
English: Lipoatrophy
Croatian: retinopatija
English: Do not use ABASAGLAR if you notice particles in it. Only use ABASAGLAR if the solution is clear, colourless and water like.
Croatian: ABASAGLAR se smije upotrijebiti samo ako je otopina bistra, bezbojna i vodenasta.
English: Package leaflet: Information for the user ABASAGLAR 100 units/mL solution for injection in a pre-filled pen insulin glargine
Croatian: Uputa o lijeku: Informacije za korisnika ABASAGLAR 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin glargin
English: Priming your pen Prime before each injection.
Croatian: Provjera protoka inzulina u brizgalici Provjerite protok inzulina u brizgalici prije svake injekcije.
English: Lipohypertrophy
Croatian: lipoatrofija
English: Step 14:
Croatian: 14. korak:
English: ABASAGLAR 100 units/mL solution for injection in a cartridge and pre-filled pen
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u ulošku i u napunjenoj brizgalici
English: Boehringer Ingelheim Pharma GmbH & Co. KG Tel: +49 (0) 800 77 90 900
Croatian: KG Tel: +49 (0) 800 77 90 900
English: Myalgia
Croatian: Hipoglikemija
English: Examples include: - you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, - your insulin pen does not work properly, - you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, - you are taking or have taken certain other medicines (see section 2, "Other medicines and
Croatian: - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, imate infekciju ili vrućicu
English: • Push the dose knob all the way in
Croatian: • Pritisnite gumb za doziranje sve do kraja.
English: - corticosteroids (such as "cortisone" used to treat inflammation), - danazol (medicine acting on ovulation), - diazoxide (used to treat high blood pressure),
Croatian: - diazoksid (koristi se za liječenje visokog krvnog tlaka) - diuretike (koriste se za liječenje visokog krvnog tlaka ili prekomjernog nakupljanja tekućine u tijelu)
English: Put on a new needle and prime the pen.
Croatian: Stavite novu iglu i provjerite protok inzulina u brizgalici.
English: • Hold your pen with the needle pointing up.
Croatian: • Držite brizgalicu iglom okrenutom prema gore.
English: ABASAGLAR 100 units/mL solution for injection in a cartridge insulin glargine
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u ulošku inzulin glargin
English: ABASAGLAR 100 units/mL injection insulin glargine
Croatian: ABASAGLAR 100 jedinica/ml, injekcija inzulin glargin s.c. primjena
English: - Skin and allergic reactions at the injection site
Croatian: Opći poremećaji i reakcije na mjestu primjene reakcije na mjestu injekcije
English: Keep Throw Away
Croatian: Držač uloška
English: Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:
Croatian: Lijekovi koji mogu uzrokovati povišenje razine šećera u krvi (hiperglikemiju) obuhvaćaju: - kortikosteroide (poput kortizona, koji se koristi za liječenje upale)
English: No new safety signals were seen during this extended treatment with insulin glargine.
Croatian: Tijekom tog produljenog liječenja inzulinom glarginom nisu otkriveni novi signali povezani sa sigurnošću primjene lijeka.
English: The cartridge is sealed in a disposable pen injector.
Croatian: Uložak je ugrađen u brizgalicu za jednokratnu uporabu.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON - Cartridge.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU VANJSKA KUTIJA - Uložak.
English: Pen Body
Croatian: Tijelo brizgalice
English: General information about the safe and effective use of your pen • Keep your pen and needles out of the sight and reach of children.
Croatian: • Brizgalicu i igle čuvajte izvan pogleda i dohvata djece.
English: • Replace the pen cap by lining up the cap clip with the dose indicator and pushing straight on.
Croatian: • Vratite zatvarač na brizgalicu tako da kvačicu poravnate s pokazivačem doze i nataknete zatvarač ravno na brizgalicu.
English: EU/1/14/944/007 5 pens EU/1/14/944/012 5 pens
Croatian: EU/1/14/944/007 5 brizgalica EU/1/14/944/012 5 brizgalica
English: Your ability to concentrate or react may be reduced if: - you have hypoglycaemia (low blood sugar levels), - you have hyperglycaemia (high blood sugar levels), - you have problems with your sight.
Croatian: - ako imate hipoglikemiju (nisku razinu šećera u krvi) - ako imate hiperglikemiju (visoku razinu šećera u krvi)
English: EU/1/14/944/008 5 pens EU/1/14/944/013 5 pens
Croatian: EU/1/14/944/008 5 brizgalica EU/1/14/944/013 5 brizgalica
English: ABASAGLAR 100 units/mL solution for injection in a pre-filled pen
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici
English: • Continue holding your pen with needle pointing up.
Croatian: • I dalje držite brizgalicu iglom okrenutom prema gore.
English: EU/1/14/944/003 5 cartridges EU/1/14/944/009 10 cartridges
Croatian: EU/1/14/944/003 5 uložaka EU/1/14/944/009 10 uložaka
English: ABASAGLAR 100 units/mL solution for injection in a cartridge
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u ulošku
English: Lilly France S.A.S.
Croatian: Eli Lilly Norge A.S.
English: ABASAGLAR 100 units/mL solution for injection in a pre-filled pen insulin glargine
Croatian: ABASAGLAR 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin glargin
English: - unaccustomed, increased or prolonged physical activity, - intercurrent illness (e.g. vomiting, diarrhoea), - inadequate food intake, - missed meals, - alcohol consumption, - certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency), - concomitant treatment with certain other medicinal products.
Croatian: - neke nekompenzirane endokrine poremećaje (npr. kod hipotireoze i insuficijencije adenohipofize ili kore nadbubrežne žlijezde),
English: Eli Lilly Hrvatska d.o.o.
Croatian: Lilly Hungária Kft.
English: 1 to 60 80 units in a single injection.
Croatian: U jednoj injekciji možete primijeniti najmanje 1, a najviše 60 80 jedinica.
English: Zinc oxide
Croatian: ugljikohidrati)
English: Dose Knob
Croatian: Prijavljivanje nuspojava
English: 10 cartridges of 3 mL
Croatian: KwikPen brizgalica 5 brizgalica od 3 ml
English: • ABASAGLAR is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
Croatian: (supkutano) na području trbuha, stražnjice,
English: Cartridge Holder
Croatian: Čuvanje brizgalice
English: Tel. +44 (0)20 7418 8427 E-mail: press@ema.europa.eu
Croatian: +44 (0)20 7418 8427 E-pošta: press@ema.europa.eu
English: 16 January 2014 EMA/35464/2014
Croatian: EMA/35464/2014
English: • If you have any questions or concerns, speak with your doctor, pharmacist or nurse.
Croatian: • Ako imate bilo kakvih pitanja ili ste zabrinuti, razgovarajte sa svojim liječnikom, ljekarnikom ili medicinskom sestrom.
English: • If you have been taking CHCs without any problem, there is no reason for you to stop taking them on the basis of this review.
Croatian: • Ako ste uzimali CHC-ove bez problema, nema razloga da ih sada prestanete uzimati na temelju ovog pregleda.
English: Not yet known1
Croatian: Nije još poznato1
English: 1 Further studies are ongoing or planned to collect sufficient data to estimate the risk for these products.
Croatian: 1 Daljnja ispitivanja su u tijeku ili planirana sa ciljem prikupljanja dovoljno podataka za procjenu rizika ovih proizvoda.
English: If you develop any of these signs and symptoms you should seek medical advice immediately.
Croatian: Ako se pojavi bilo koji od ovih znakova i simptoma, morate odmah potražiti liječničku pomoć.
English: • You should discuss with your doctor or nurse what is the most appropriate type of contraception for you.
Croatian: • S liječnikom ili medicinskom sestrom morate raspraviti koji je najprimjereniji tip kontracepcije za Vas.
English: Contact our press officers Monika Benstetter or Martin Harvey
Croatian: Naši službenike za odnose s javnošću: Monika Benstetter ili Martin Harvey
English: The classification as ‘second, third or fourth generation' is however not science-based and not standardised, and may differ between institutions and publications.
Croatian: Klasifikacija „druga, treća ili četvrta generacija” ne temelji se na znanosti i nije standardizirana, te se može razlikovati od institucije do institucije te od publikacije do publikacije.
English: The review of combined hormonal contraceptives was initiated in February 2013 at the request of France, under Article 31 of Directive 2001/83/EC.
Croatian: Pregled kombiniranih hormonalnih kontraceptiva pokrenut je u veljači 2013. na zahtjev Francuske sukladno članku 31. Direktive 2001/83/EZ.
English: Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks
Croatian: Koristi od kombiniranih hormonalnih kontraceptiva (CHCova) nadmašuju i dalje rizike
English: • Because a woman's individual risk factors will change over time, there is a need to regularly reassess the suitability of her contraceptive.
Croatian: • Budući da će se individualni faktori rizika žene promijeniti tijekom vremena, postoji potreba za redovitom ponovnom ocjenom pogodnosti njezinog kontraceptiva.
English: These are sometimes referred to as ‘third generation' or ‘fourth generation' contraceptives and are available as pills, skin patches and vaginal rings.
Croatian: Njih se ponekad naziva i kontraceptivima „treće generacije” ili „četvrte generacije” i dostupni su kao tablete, flasteri za kožu i vaginalni prsteni.
English: But it is important that you are aware of the risk of blood clots associated with these medicines, even though it is very low.
Croatian: No važno je da ste upoznati s rizikom od krvnih ugrušaka koji je povezan s ovim lijekovima, iako je taj rizik vrlo nizak.
English: This risk is very low and there is no evidence for a difference in the level of risk between products depending on the type of progestogen.
Croatian: Ovaj je rizik vrlo nizak te ne postoje dokazi o razlikama u razini rizika između proizvoda ovisno o tipu progestogena.
English: • When taking CHCs, you should be alert for the signs and symptoms of blood clots, which may include severe pain or swelling in the legs, sudden unexplained breathlessness, rapid breathing or cough, chest pain, and weakness or numbness of the face, arm or leg.
Croatian: • Prilikom primjene CHC-a morate biti na oprezu kako biste uočili znakove i simptome krvnih ugrušaka, koji mogu uključivati ozbiljnu bol ili oticanje u nogama, iznenadnu i neobjašnjenu zadihanost, brzo disanje ili kašalj, bol u prsima i slabost ili utrnulost lica, ruku ili nogu.
English: This compares with 2 cases of blood clots in the veins each year per 10,000 women who are not using CHCs.
Croatian: U tabeli su uspoređena 2 slučaja krvnih ugrušaka u venama svake godine na 10.000 žena koje nisu koristile CHC-ove.
English: Risk of developing a blood clot (VTE) in a year Women not using a combined hormonal pill/patch/ring and are not pregnant
Croatian: Rizik od razvoja krvnih ugrušaka (VTE) u godini Žene koje ne koriste kombinirane hormonalne tablete/flastere/prsten te nisu trudne
English: • The risk of blood clots in the veins varies between CHCs, depending on the type of progestogen (a hormone) they contain, and ranges from 5 to 12 cases of blood clots per 10,000 women who use them for a year (see table below).
Croatian: • Rizik od krvnih ugrušaka u venama varira ovisno o CHC-ovima, i to ovisno o tipu progestogena (hormona) kojeg sadrže, i raspona od 5 do 12 slučajeva krvnih ugrušaka na 10.000 žena koje su ih koristile tijekom godine dana (vidjeti tabelu niže u tekstu).
English: With the exception of Zoely (nomegestrol acetate/estradiol), Ioa (nomegestrol acetate/estradiol) and Evra (norelgestromin/ethinylestradiol), which have been authorised centrally through the EMA, all other combined contraceptives in the EU have been authorised via national procedures.
Croatian: Uz iznimku lijekova Zoely (nomegestrol acetat/estradiol), Ioa (nomegestrol acetat/estradiol) i Evra (norelgestromin/etinilestradiol), koji su odobreni centralno od strane EMA, svi ostali kombinirani kontraceptivi odobreni su u EU-u putem nacionalnih postupaka.
English: CHCs are contraindicated if a woman has one serious or multiple risk factors that put her at high risk of blood clots.
Croatian: CHC-ovi su kontraindicirani ako kod žene postoji jedan ozbiljan ili nekoliko faktora rizika koji su izlažu visokom riziku od krvnih ugrušaka.
English: The review also looked at the risk of arterial thromboembolism (ATE, blood clots in arteries, which can potentially cause a stroke or heart attack).
Croatian: Pregled je također istražio i rizik od arterijske tromboembolije (ATE, krvni ugrušci u arterijama, koji mogu potencijalno uzrokovati moždani udar ili infarkt miokarda).